Clinical trials
Observational Asthma trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 4 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Recruiting | 7 |
| Terminated | 3 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 9 |
| Johann Wolfgang Goethe University Hospital | 3 |
| RWTH Aachen University | 3 |
| Universitätsklinikum Hamburg-Eppendorf | 3 |
| Chiesi Farmaceutici S.p.A. | 2 |
| Universitätsmedizin Mannheim | 2 |
| Ayham Daher | 1 |
| Boehringer Ingelheim | 1 |
| Bosch Healthcare Solutions GmbH | 1 |
| Boston Scientific Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asthma | 41 |
| Pulmonary Disease, Chronic Obstructive | 14 |
| Anxiety Disorders | 3 |
| Arrhythmias, Cardiac | 3 |
| Coronary Disease | 3 |
| Depressive Disorder | 3 |
| Diabetes Mellitus, Type 1 | 3 |
| Diabetes Mellitus, Type 2 | 3 |
| Heart Failure | 3 |
| Ischemic Attack, Transient | 3 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.